Skip to content

Serotonine in cocaine dependence: towards novel diagnostic markers for addicts responsive to behavioural-cognitive therapy

Serotonine in cocaine dependence: towards novel diagnostic markers for addicts responsive to behavioural-cognitive therapy - serocaine

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON36394
Enrollment
100
Registered
2011-06-16
Start date
2011-04-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

verslaving cocaine addiction

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Male subjects with cocaine dependence as defined in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV; American Psychiatric Association 1994), and will be determined by a structured interview (Composite International Diagnostic Interview: CIDI) aged 18-40 years. Controls: male healthy volunteers aged 18-40 years.

Exclusion criteria

Exclusion criteria: No cocaine dependence Positive DSM-IV/CIDI for any drug other than cocaine, heroin, alcohol or marijuana Major neurological disorders, claustrophobia, peripheral vascular diseases, current use of respiratory, cardiovascular, anticonvulsant or psychoactive medications (SSRIs), or alexithymia A positive urine test result for amphetamines, barbiturates, benzodiazepine metabolites, cocaine (metabolite), opiates, alcohol, and marijuana

Design outcomes

Primary

MeasureTime frame
- Vigilance level (an fMRI task): % BOLD signal change in the ventral frontostriatal circuit (which is associated with reversal learning). - 5HTT function (a phMRI study): peak amplitude (maximum % change relative to baseline) in cerebral blood flow (CBF) evoked by an acute pharmacological challenge with citalopram.

Secondary

MeasureTime frame
none

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)